HUP0202114A3 - Use of benzoic acid substituted benzopyrans in medicines useful for the treatment of atherosclerosis and the medicines - Google Patents
Use of benzoic acid substituted benzopyrans in medicines useful for the treatment of atherosclerosis and the medicinesInfo
- Publication number
- HUP0202114A3 HUP0202114A3 HU0202114A HUP0202114A HUP0202114A3 HU P0202114 A3 HUP0202114 A3 HU P0202114A3 HU 0202114 A HU0202114 A HU 0202114A HU P0202114 A HUP0202114 A HU P0202114A HU P0202114 A3 HUP0202114 A3 HU P0202114A3
- Authority
- HU
- Hungary
- Prior art keywords
- medicines
- atherosclerosis
- treatment
- benzoic acid
- acid substituted
- Prior art date
Links
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 title 2
- 239000003814 drug Substances 0.000 title 2
- 229940079593 drug Drugs 0.000 title 2
- 201000001320 Atherosclerosis Diseases 0.000 title 1
- 239000005711 Benzoic acid Substances 0.000 title 1
- 235000010233 benzoic acid Nutrition 0.000 title 1
- 150000001562 benzopyrans Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30171201P | 2001-06-28 | 2001-06-28 | |
US32825401P | 2001-10-10 | 2001-10-10 |
Publications (3)
Publication Number | Publication Date |
---|---|
HU0202114D0 HU0202114D0 (hu) | 2002-09-28 |
HUP0202114A2 HUP0202114A2 (hu) | 2003-01-28 |
HUP0202114A3 true HUP0202114A3 (en) | 2004-07-28 |
Family
ID=26972559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0202114A HUP0202114A3 (en) | 2001-06-28 | 2002-06-27 | Use of benzoic acid substituted benzopyrans in medicines useful for the treatment of atherosclerosis and the medicines |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1270000A3 (hu) |
JP (1) | JP2003034638A (hu) |
KR (1) | KR20030015828A (hu) |
CN (1) | CN1394602A (hu) |
AU (1) | AU4239302A (hu) |
CA (1) | CA2391205A1 (hu) |
CZ (1) | CZ20022076A3 (hu) |
HK (1) | HK1049795A1 (hu) |
HU (1) | HUP0202114A3 (hu) |
IL (1) | IL150340A0 (hu) |
PL (1) | PL354770A1 (hu) |
SK (1) | SK8682002A3 (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4476934B2 (ja) * | 2003-04-14 | 2010-06-09 | 明治乳業株式会社 | 新規ペプチドおよび免疫賦活剤、機能性食品ならびに機能性食品の製造方法 |
RU2007101510A (ru) * | 2004-07-22 | 2008-08-27 | Фармаци Корпорейшн (US) | Композиции для лечения воспаления и боли с использованием комбинации селективного ингибитора сох-2 и антагониста рецептора ltb4 |
PL1888033T3 (pl) * | 2005-06-09 | 2014-09-30 | Meda Ab | Sposób i kompozycja do leczenia chorób zapalnych |
EP3383388B1 (en) | 2015-11-30 | 2021-04-14 | Merck Sharp & Dohme Corp. | Aryl acylsulfonamides as blt1 antagonists |
EP3383389B1 (en) * | 2015-11-30 | 2021-04-28 | Merck Sharp & Dohme Corp. | Aryl acylsulfonamides as blt1 antagonists |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3720493A1 (de) * | 1987-06-20 | 1989-01-26 | Nattermann A & Cie | Arzneizubereitungen mit mikronisierten ebselen-kristallen |
MX9300312A (es) * | 1992-01-23 | 1993-07-31 | Pfizer | Antagonistas benzopiranicos y relacionado de ltb. |
DE4228200A1 (de) * | 1992-08-25 | 1994-03-03 | Schering Ag | Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung |
CN1160399A (zh) * | 1994-10-13 | 1997-09-24 | 美国辉瑞有限公司 | 苯并吡喃和苯并稠合化合物、其制备方法和它们作为白三烯b4(ltb4)拮抗剂的用途 |
JP3012339B2 (ja) * | 1994-10-13 | 2000-02-21 | ファイザー・インコーポレーテッド | ベンゾピランおよびベンゾ縮合化合物、それらの製造、並びにロイコトリエンb▲下4▼(ltb▲下4▼)アンタゴニストとしてのそれらの用途 |
CA2224563A1 (en) * | 1995-06-12 | 1996-12-27 | G.D. Searle & Co. | Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
DE19636689A1 (de) * | 1996-09-10 | 1998-03-12 | Boehringer Ingelheim Kg | Neue Benzamidinderivate |
CA2265043C (en) * | 1996-09-16 | 2003-01-14 | Pfizer Inc. | Processes and intermediates for preparing substituted chromanol derivatives |
EP0963755A3 (en) * | 1998-04-16 | 2001-03-14 | Pfizer Products Inc. | Use of benzopyranes for preventing allograft rejection |
AU5687199A (en) * | 1998-08-24 | 2000-03-14 | Global Vascular Concepts, Inc. | Use of anti-angiogenic agents for inhibiting vessel wall injury |
JP2003225088A (ja) * | 1999-09-10 | 2003-08-12 | Meiji Seika Kaisha Ltd | ヒト・ロイコトリエンb4第二受容体及びそれをコードするdna |
US20040091863A1 (en) * | 2000-03-17 | 2004-05-13 | Shyam Ramakrishnan | Regulation of human leukotriene b4-like g protein-coupled receptor |
-
2002
- 2002-05-20 AU AU42393/02A patent/AU4239302A/en not_active Abandoned
- 2002-06-13 CZ CZ20022076A patent/CZ20022076A3/cs unknown
- 2002-06-17 SK SK868-2002A patent/SK8682002A3/sk not_active Application Discontinuation
- 2002-06-19 EP EP02254274A patent/EP1270000A3/en not_active Withdrawn
- 2002-06-20 IL IL15034002A patent/IL150340A0/xx unknown
- 2002-06-25 CA CA002391205A patent/CA2391205A1/en not_active Abandoned
- 2002-06-26 JP JP2002185853A patent/JP2003034638A/ja not_active Withdrawn
- 2002-06-27 KR KR1020020036449A patent/KR20030015828A/ko not_active Application Discontinuation
- 2002-06-27 HU HU0202114A patent/HUP0202114A3/hu unknown
- 2002-06-27 PL PL02354770A patent/PL354770A1/xx not_active Application Discontinuation
- 2002-06-28 CN CN02125125A patent/CN1394602A/zh active Pending
-
2003
- 2003-03-17 HK HK03101939.9A patent/HK1049795A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR20030015828A (ko) | 2003-02-25 |
SK8682002A3 (en) | 2004-08-03 |
CZ20022076A3 (cs) | 2004-05-12 |
EP1270000A3 (en) | 2003-02-12 |
PL354770A1 (en) | 2002-12-30 |
HU0202114D0 (hu) | 2002-09-28 |
CN1394602A (zh) | 2003-02-05 |
CA2391205A1 (en) | 2002-12-28 |
HUP0202114A2 (hu) | 2003-01-28 |
JP2003034638A (ja) | 2003-02-07 |
IL150340A0 (en) | 2002-12-01 |
EP1270000A2 (en) | 2003-01-02 |
HK1049795A1 (zh) | 2003-05-30 |
AU4239302A (en) | 2003-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0302845A3 (en) | 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical | |
IL157731A0 (en) | Caboxylic acid derivatives and pharmaceutical compositions containing the same | |
PT1757606E (pt) | Utilização de derivados de xantina como produto farmacêutico, bem como seu processo de preparação | |
EP1367060A4 (en) | GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE | |
EP1364957A4 (en) | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE | |
EP1364958A4 (en) | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF | |
AU2001277741A1 (en) | 2-aminopyridine compounds and use thereof as drugs | |
IL155196A0 (en) | Benzamide derivatives and pharmaceutical compositions containing the same | |
IL159547A0 (en) | Novel vinyl carboxylic acid derivatives and their use as antidiabetics | |
GB0108470D0 (en) | Pharmaceutical compositions and their use | |
IL159084A0 (en) | Tetrahydroisoquinoline carboxylic acid derivatives and pharmaceutical compositions containing the same | |
HUP0202114A3 (en) | Use of benzoic acid substituted benzopyrans in medicines useful for the treatment of atherosclerosis and the medicines | |
AU2001250933A1 (en) | Chitosan formulation with azelaic acid and other actives for the treatment of acne | |
IL161163A0 (en) | Anthranilic acid amides and pharmaceutical use thereof | |
AU2002342889A1 (en) | Anthranilic acid amides and pharmaceutical use thereof | |
HUP0302136A3 (en) | Gallic acid derivatives and use for exploring endogenetic coagulation | |
AU7402201A (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
GB9922710D0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis | |
GB0026923D0 (en) | Veterinary composition for the topical treatment of traumatized or inflamed skin | |
GB0007217D0 (en) | Materials and methods relating to the treatment of leukaemias | |
IL143795A0 (en) | Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections | |
HUP0402242A3 (en) | Use of 4-oxobutanoic acid derivatives in the treatment of inflammation | |
AU2002346849A1 (en) | Use of hydroxyoleic acid and similar compounds in the production of medicaments | |
ZA200205093B (en) | Benzoic acid substituted benzopyrans for the treatment of atherosclerosis. | |
AU2002368208A8 (en) | Use of 2,3 alkylcarbonyloxybenzoic acids in the treatment of anthrax |